Cogent Biosciences (COGT) Treasury Shares (2019 - 2025)

Cogent Biosciences' Treasury Shares history runs 4 years deep, the most recent figure standing at $4.0 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 47.02% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 47.02% YoY), while the FY2025 annual figure was $4.0 million, up 47.02% from the prior year.
• Treasury Shares was $4.0 million for Q4 2025 at Cogent Biosciences, up from $2.7 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.0 million in Q4 2025 to a low of $2.5 million in Q4 2023.
• Historically, Treasury Shares has averaged $3.1 million across 3 years, with a median of $2.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares climbed 8.56% in 2024, then soared 47.02% in 2025.
• A 3-year view of Treasury Shares shows it stood at $2.5 million in 2023, then increased by 8.56% to $2.7 million in 2024, then soared by 47.02% to $4.0 million in 2025.
• The last three Treasury Shares figures came in at $4.0 million (Q4 2025), $2.7 million (Q4 2024), and $2.5 million (Q4 2023), per Business Quant data.